Developing a prediction rule to assesss hepatic malignancy in patients with cirrhosis

American Journal of Roentgenology

Volumn 180, Issue 4, 2003, Pages 893-900

  Carlos, Ruth C ^a   Kim, H Myra ^b   Hussain, Hero K ^a   Francis, Issac R ^a   Nghiem, Hanh V ^a   Fendrick, A Mark ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; GADOLINIUM;

ADULT; AGE DISTRIBUTION; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER CLASSIFICATION; CHI SQUARE DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SEX DIFFERENCE; TUMOR BIOPSY; TUMOR VOLUME;

EID: 0345268715     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.180.4.1800893     Document Type: Article

References (31)

1. Semelka RC, Martin DR, Balci C, Lance T. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 2001;13:397-401
2. Tomemori T, Yamakado K, Nakatsuka A, Sakuma H, Matsumura K, Takeda K. 3D dynamic MR imaging of the liver with MR SmartPrep: comparison with helical CT in detecting hypervascular hepatocellular carcinoma. Clin Imaging 2001;25:355-361
3. Kelekis N, Semelka R, Worawattanakul S, et al. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. AJR 1998;170:1005-1013
4. Yamashita Y, Mitsuzaki K, Yi T, et al. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 1996;200:79-84
5. Pawluk RS, Tummala S, Brown JJ, Borrello JA. A retrospective analysis of the accuracy of T2-weighted images and dynamic gadolinium-enhanced sequences in the detection and characterization of focal hepatic lesions. J Magn Reson Imaging 1999;9:266-273
6. Larson RE, Semelka RC, Bagley AS, Molina PL, Brown ED, Lee JK. Hypervascular malignant liver lesions: comparison of various MR imaging pulse sequences and dynamic CT. Radiology 1994;192:393-399
7. Semelka RC, Shoenut JP, Kroeker MA, et al. Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T. Radiology 1992;184:687-694
8. Hamm B, Mahfouz AE, Taupitz M, et al. Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging? Radiology 1997;202:677-682
9. Ward J, Baudouin CJ, Ridgway JP, Robinson PJ. Magnetic resonance imaging in the detection of focal liver lesions: comparison of dynamic contrast-enhanced turboFLASH and T2 weighted spin echo images. Br J Radiol 1995;68:463-470
10. Earls JP, Theise ND, Weinreb JC, et al. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 1996;201:207-214
11. Itai Y, Ohnishi S, Ohtomo K, et al. Regenerating nodules of liver cirrhosis: MR imaging. Radiology 1987;165:419-423
12. Semelka RC, Chung JJ, Hussain SM, Marcos HB, Woosley JT. Chronic hepatitis: correlation of early patchy and late linear enhancement patterns on gadolinium-enhanced MR images with histopathology initial experience. J Magn Reson Imaging 2001;13:385-391
13. Freeney PC, Kaakji K, Grossholz ME, Schmiedl UP, Nghiem HV. The significance of hypervascular hepatic nodules. (abstr) Radiology 1999;213(P):335
14. Seltzer SE, Getty DJ, Pickett RM, et al. Multimodality diagnosis of liver tumors: feature analysis with CT, liver-specific and contrast-enhanced MR, and a computer model. Acad Radiol 2002;9:256-269
15. Hamm B, Thoeni RF, Gould RG, et al. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology 1994;190:49-52
16. Tello R, Fenlon HM, Gagliano T, deCarvalho VL, Yucel EK. Prediction rule for characterization of hepatic lesions revealed on MR imaging: estimation of malignancy. AJR 2001;176:879-884
17. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference - European Association for the Study of the Liver. J Hepatol 2001;35:421-430
18. Colombo M, de Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-680
19. Degos F, Christidis C, Ganne-Carrie N, et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 2000;47:131-136
20. Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994;19:61-66
21. Lemeshow S. The multiple logistic regression model. In: Hosmer DW, ed. Applied logistic regression. New York: Wiley, 1989:25-27
22. Efron B, Tibshirani R. Statistical data analysis in the computer age. Science 1991;253:390-395
23. Efron B, Tibshirani R. An introduction to the bootstrap. London: Chapman and Hall, 1993
24. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. NIH conference: hepatocellular carcinoma. Ann Intern Med 1988;108:390-401
25. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991;22:172-178
26. Takayama T, Makuuchi M, Hirohashi S, et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 1990;336:1150-1153
27. Sadek AG, Mitchell DG, Siegelman ES, Outwater EK, Matteucci T, Hann HW. Early hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imaging. Radiology 1995;195:753-756
28. Gogel BM, Goldstein RM, Kuhn JA, McCarty TM, Donahoe A, Glastad K. Diagnostic evaluation of hepatocellular carcinoma in a cirrhotic liver. Oncology 2000;14:15-20
29. Krinsky GA, Lee VS, Theise ND, et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 2001;219:445-454
30. Mitchell DG, Saini S, Weinreb J, et al. Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Radiology 1994;193:49-57
31. Peterson MS, Baron RL, Marsh JW Jr, Oliver JH 3rd, Confer SR, Hunt LE. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology 2000;217:743-749